These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 9888307

  • 21. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin.
    Cui F, He C, He M, Tang C, Yin L, Qian F, Yin C.
    J Biomed Mater Res A; 2009 Jun 15; 89(4):1063-71. PubMed ID: 18478558
    [Abstract] [Full Text] [Related]

  • 22. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Jun 15; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]

  • 23. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S, Sharma CP.
    Int J Pharm; 2006 Nov 15; 325(1-2):147-54. PubMed ID: 16859846
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR, Sharma CP.
    J Control Release; 2009 Apr 17; 135(2):144-51. PubMed ID: 19331862
    [Abstract] [Full Text] [Related]

  • 25. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK, Hinkers SC.
    J Agric Food Chem; 2004 Jun 30; 52(13):4219-26. PubMed ID: 15212472
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins.
    Bernkop-Schnürch A, Scerbe-Saiko A.
    Pharm Res; 1998 Feb 30; 15(2):263-9. PubMed ID: 9523313
    [Abstract] [Full Text] [Related]

  • 27. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 30; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF, Thanou MM, Luebetaen HL, de Boer AG, Verhoef JC, Junginger HE.
    J Pharm Sci; 1999 Feb 30; 88(2):253-7. PubMed ID: 9950647
    [Abstract] [Full Text] [Related]

  • 29. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 30; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 30. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP, Zamolodchikova TS, Sokolova EA, Larionova NI.
    Biochemistry (Mosc); 1999 Nov 30; 64(11):1244-9. PubMed ID: 10611528
    [Abstract] [Full Text] [Related]

  • 31. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR, Fritz H, Auerswald EA, Mentele R, Sampaio M, Sampaio CA, Oliva ML.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):838-43. PubMed ID: 10441512
    [Abstract] [Full Text] [Related]

  • 32. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
    Ascenzi P, Amiconi G, Bolognesi M, Menegatti E, Guarneri M.
    J Mol Recognit; 1990 Aug 11; 3(5-6):192-6. PubMed ID: 2096886
    [Abstract] [Full Text] [Related]

  • 33. Chitosan: a unique polysaccharide for drug delivery.
    Felt O, Buri P, Gurny R.
    Drug Dev Ind Pharm; 1998 Nov 11; 24(11):979-93. PubMed ID: 9876553
    [Abstract] [Full Text] [Related]

  • 34. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
    Werle M, Kafedjiiski K, Kolmar H, Bernkop-Schnürch A.
    Int J Pharm; 2007 Mar 06; 332(1-2):72-9. PubMed ID: 17070661
    [Abstract] [Full Text] [Related]

  • 35. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N.
    Bernkop-Schnürch A, Paikl C, Valenta C.
    Pharm Res; 1997 Jul 06; 14(7):917-22. PubMed ID: 9244150
    [Abstract] [Full Text] [Related]

  • 36. Design and in vivo evaluation of an oral delivery system for insulin.
    Marschütz MK, Caliceti P, Bernkop-Schnürch A.
    Pharm Res; 2000 Dec 06; 17(12):1468-74. PubMed ID: 11303955
    [Abstract] [Full Text] [Related]

  • 37. Chemically modified chitosans as enzyme inhibitors.
    Bernkop-Schnürch A, Kast CE.
    Adv Drug Deliv Rev; 2001 Nov 05; 52(2):127-37. PubMed ID: 11718936
    [Abstract] [Full Text] [Related]

  • 38. Exploiting the synergistic effect of chitosan-EDTA conjugate with MSA for the early recovery from colitis.
    Singh K, Suri R, Tiwary AK, Rana V.
    Int J Biol Macromol; 2013 Mar 05; 54():186-96. PubMed ID: 23270836
    [Abstract] [Full Text] [Related]

  • 39. Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting.
    Ekrami H, Kennedy AR, Shen WC.
    J Pharm Sci; 1995 Apr 05; 84(4):456-61. PubMed ID: 7629736
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.